JP2005314380A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005314380A5 JP2005314380A5 JP2005088634A JP2005088634A JP2005314380A5 JP 2005314380 A5 JP2005314380 A5 JP 2005314380A5 JP 2005088634 A JP2005088634 A JP 2005088634A JP 2005088634 A JP2005088634 A JP 2005088634A JP 2005314380 A5 JP2005314380 A5 JP 2005314380A5
- Authority
- JP
- Japan
- Prior art keywords
- insulin resistance
- agent
- improving agent
- insulin
- diabetes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010022489 Insulin Resistance Diseases 0.000 claims 30
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 30
- 239000003795 chemical substances by application Substances 0.000 claims 25
- 239000003814 drug Substances 0.000 claims 16
- 206010012601 diabetes mellitus Diseases 0.000 claims 10
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- XMSXOLDPMGMWTH-UHFFFAOYSA-N rivoglitazone Chemical group CN1C2=CC(OC)=CC=C2N=C1COC(C=C1)=CC=C1CC1SC(=O)NC1=O XMSXOLDPMGMWTH-UHFFFAOYSA-N 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 7
- 239000004480 active ingredient Substances 0.000 claims 6
- 229940079593 drug Drugs 0.000 claims 6
- 229940122355 Insulin sensitizer Drugs 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 239000008280 blood Substances 0.000 claims 3
- 210000004369 blood Anatomy 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- 208000002705 Glucose Intolerance Diseases 0.000 claims 2
- 239000008103 glucose Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 201000009104 prediabetes syndrome Diseases 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 238000010790 dilution Methods 0.000 claims 1
- 239000012895 dilution Substances 0.000 claims 1
- 230000002641 glycemic effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005088634A JP2005314380A (ja) | 2004-03-29 | 2005-03-25 | インスリン抵抗性改善剤を含有する糖尿病治療剤 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004094598 | 2004-03-29 | ||
| JP2005088634A JP2005314380A (ja) | 2004-03-29 | 2005-03-25 | インスリン抵抗性改善剤を含有する糖尿病治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005314380A JP2005314380A (ja) | 2005-11-10 |
| JP2005314380A5 true JP2005314380A5 (pt) | 2008-04-24 |
Family
ID=35442165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005088634A Withdrawn JP2005314380A (ja) | 2004-03-29 | 2005-03-25 | インスリン抵抗性改善剤を含有する糖尿病治療剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2005314380A (pt) |
-
2005
- 2005-03-25 JP JP2005088634A patent/JP2005314380A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2519660C2 (ru) | Режим дозировки селективного агониста рецептора s1p1 | |
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| JP2019517542A5 (pt) | ||
| JP2012520866A5 (pt) | ||
| JP2018507243A5 (pt) | ||
| JP2010540519A5 (pt) | ||
| JP2009506043A5 (pt) | ||
| JP2020529440A5 (pt) | ||
| Park et al. | Modified titanium implant as a gateway to the human body: the implant mediated drug delivery system | |
| JP2018509419A5 (pt) | ||
| JP2013536837A5 (pt) | ||
| BR122021012549B1 (pt) | Composição de dissolução oral de melatonina com agente acidificante que torna melatonina solúvel em saliva | |
| JP2020536121A5 (pt) | ||
| BR112019026029A2 (pt) | Formulações farmacêuticas orais de remogliflozina | |
| JP2012502105A5 (pt) | ||
| CN101437530A (zh) | 一种烟叶提取物及其在依赖治疗中的应用 | |
| JP2009501707A5 (pt) | ||
| JP2006508118A5 (pt) | ||
| KR20200136008A (ko) | 신경퇴행성 장애의 치료를 위한 약제학적 조성물의 연속 투여 | |
| JP2005314380A5 (pt) | ||
| JP2001039976A5 (pt) | ||
| JP6420923B1 (ja) | 医薬 | |
| JP6454436B1 (ja) | ペマフィブラートを含有する医薬 | |
| CN102648915B (zh) | 一种治疗或预防神经病理性疼痛的药物组合物 | |
| WO2016001185A1 (en) | Dosage regimen for the treatment of diabetes |